Suspended NCT04031469
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In Ventura Bipolarity, Depression, ... Other Over 12 Years
Countries United States
Sponsor ProgenaBiome
Condition Bipolarity, Depression, ... Completed NCT01053429
This study is completed in Global. It focuses on Schizophrenia.
In Global Schizophrenia, Bipolarity Drug i A study involving a medication or substance.
Countries Global
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia, Bipolarity Withdrawn NCT04811404
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In New York Bipolarity Drug From 18 Years to 60 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Bipolarity Completed NCT02189057
This study is completed. It focuses on depression and currently lists study information in the United States.
In Rochester Depression, Bipolarity Other From 18 Years to 65 Years
Countries United States
Sponsor Mayo Clinic
Condition Depression, Bipolarity Completed NCT01986101
This study is completed. It focuses on bipolarity and currently lists study information in Japan, Lithuania, Malaysia, the Philippines, Russian Federation, Slovakia, Taiwan, and Ukraine.
Multiple locations, including Tokyo Bipolarity, Depression Drug From 18 Years to 74 Years
Countries Japan, Lithuania, Malaysia, ...
Sponsor Sumitomo Pharma Co., Ltd.
Condition Bipolarity, Depression Completed NCT00277212
This study is completed in the United States. It is testing safety and Efficacy of Aripiprazole for Bipolarity.
Multiple locations, including Birmingham Bipolarity Drug Over 18 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity Terminated NCT00535262
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In New York Bipolarity, Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Bipolarity, Depression Suspended NCT02719392
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In Boston Bipolarity, Depression Behavioral From 18 Years to 65 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Bipolarity, Depression Completed NCT03774641
This study is completed. It focuses on depression and currently lists study information in the United States.
In Baltimore Depression, Bipolarity Drug Over 18 Years
Countries United States
Sponsor Johns Hopkins University
Condition Depression, Bipolarity Completed NCT00699218
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In Davis Bipolarity, Depression Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 65 Years
Countries United States
Sponsor University of California, Davis
Condition Bipolarity, Depression Completed NCT02476877
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In Brooklyn Schizophrenia, Bipolarity, ... Other Over 18 Years
Countries United States
Sponsor Advanced Clinical Laboratory Solutions, Inc.
Condition Schizophrenia, Bipolarity, ... Completed NCT00593099
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In New Haven Bipolarity Drug From 18 Years to 65 Years
Countries United States
Sponsor National Institute on Drug Abuse (NIDA)
Condition Bipolarity 
